[Effect of beclomethasone increment on airflow limitation in asthmatic children treated with high dose beclomethasone].
In order to evaluate the effect of higher dose BDP therapy (1200-1660 micrograms/day), we studied 12 asthmatic children (mean age 9.7 years-old) with airflow limitation on respiratory function test who were asymptomatic with high-dose BDP therapy (800 micrograms/day). After 4 weeks of higher dose BDP therapy, FVC, FEV1 and V50 were significantly improved, but those improvement were insufficient compared with those after salbutamol inhalation. The personal best values after salbutamol inhalation were not different in every parameter of respiratory function test between BDP 800 micrograms/day and 1200 micrograms/day. We conclude that less than 800 micrograms of daily BDP is generally adequate for prevention in most asthmatic children, because higher dose BDP therapy is no more effective on respiratory function in those treated with 800 micrograms of daily BDP, and that the best value of respiratory function after salbutamol inhalation is not always a goal of high dose BDP therapy.
Inoue
T
T
Department of Pediatric Allergy, Osaka Prefectural Habikino Hospital.
Takamatsu
I
I
Kameda
M
M
Murayama
N
N
Doi
S
S
Toyoshima
K
K
D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001507:Beclomethasone / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D012119:Respiration / Q000187:drug effects*; D012129:Respiratory Function Tests
D018927:Anti-Asthmatic Agents; D001507:Beclomethasone